Open roles at Alchemab Therapeutics
Latest Alchemab Therapeutics Signals
What they do
Alchemab Therapeutics has successfully extended its Series A financing with a $34 million investment led by the British Business Bank. This funding, which brings the total Series A investment to £109 million, will be utilized to enhance its clinical pipeline and expand its proprietary antibody dataset, crucial for developing novel therapeutics.
Why it matters
Alchemab leverages its Resiliome platform to discover protective antibodies from individuals who are naturally resistant to diseases, aiming to develop innovative treatments for hard-to-treat conditions. The platform integrates advanced AI with a vast antibody database, enabling the identification of potential new medicines.
Traction
Alchemab's first antibody therapy, ATLX-1282, is currently in clinical development for amyotrophic lateral sclerosis (ALS) and has been licensed to Eli Lilly, showcasing the platform's validation. The company is expanding its antibody database from 500 million to over 1 billion sequences, indicating significant growth potential in its drug discovery capabilities.
Where the market is going
Alchemab is positioned to disrupt traditional drug discovery methods by harnessing the body's natural defenses against disease, a shift that threatens established players in the biotech space. The integration of AI with extensive biological data represents a structural change in how therapeutics are developed, potentially leading to faster and more effective treatments for conditions with significant unmet needs.
Why Alchemab Therapeutics is hiring
Alchemab Therapeutics closed a $34M funding round in July 2026, with investors including British Business Bank, SV Health Investors and Eli Lilly. It currently has 1 open role, with hiring concentrated in Whittlesford.
Teams hiring
Where Alchemab Therapeutics hires
Similar Health companies hiring
Alchemab Therapeutics jobs: common questions
Is Alchemab Therapeutics hiring?
Yes. Alchemab Therapeutics has 1 open role on SuperAIJobs right now. The list is refreshed daily from Alchemab Therapeutics’s own careers site.
Where are Alchemab Therapeutics jobs located?
Most open roles at Alchemab Therapeutics are in Whittlesford.
Does Alchemab Therapeutics hire remotely?
None of Alchemab Therapeutics’s current roles are listed as remote, so expect to work from one of its offices.
How much has Alchemab Therapeutics raised?
The latest round we track is a $34M funding round in July 2026. Investors include British Business Bank, SV Health Investors and Eli Lilly. See the full deal history on MapCo.
What does Alchemab Therapeutics do?
Alchemab leverages its Resiliome platform to discover protective antibodies from individuals who are naturally resistant to diseases, aiming to develop innovative treatments for hard-to-treat conditions.
How do I apply for a job at Alchemab Therapeutics?
Every role on this page links straight to Alchemab Therapeutics’s own application page, so you apply directly — SuperAIJobs never sits in between.